LCID
Lucid Group, Inc.
LCID has the edge over PLBY overall, supported by stronger fundamentals and stronger modeled upside.
PLBY
Playboy, Inc.
PLBY has slightly lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PLBY Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Weak | |
| Weak |
PLBY's profitability is currently healthy, but its revenue, cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PLBY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 31x | $1.22 | — |
| Forward | 31x | $1.22 | — |
| Cheap | 49x | $1.98 | +62% |
| Fair | 54x | $2.15 | +76% |
| Expensive | 60x | $2.39 | +96% |
Historical ranges are pointers, not guarantees.
PLBY's PE is 31x, but its earnings don't support one, so it isn't a reliable read right now.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PLBY Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| -- | |
| Limited | |
| -- |
Analysts expect earnings and revenue growth for PLBY, with profitability holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
PLBY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.04 | 0% |
| Q3 2026 | $0.04 | +$0.35 |
| Q2 2026 | $0.02 | +$0.78 |
| Q1 2026 | -$0.06 | +$0.85 |
| Q4 2025 | -$0.13 | +$0.91 |
| Q3 2025 | -$0.31 | +$0.69 |
| Q2 2025 | -$0.76 | -$0.11 |
| Q1 2025 | -$0.91 | +$1.27 |
| Q4 2024 | -$1.04 | +$1.49 |
PLBY has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PLBY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PLBY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $31.7M | +9.4% |
| Q2 2026 | $31.2M | +11% |
| Q1 2026 | $30.2M | +4.7% |
| Q4 2025 | $34.9M | -58% |
| Q3 2025 | $29M | +125% |
| Q2 2025 | $28.1M | +13% |
| Q1 2025 | $28.9M | +2% |
| Q4 2024 | $83.3M | +112% |
PLBY's revenue is recovering but still below its 2021 peak: $32M last quarter, up 9.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +7.9 points |
| Q2 2026 | 9.5% | +30 points |
| Q1 2026 | -5.4% | +16 points |
| Q4 2025 | 7.9% | +16 points |
| Q3 2025 | 4.7% | +224 points |
| Q2 2025 | -21% | +16 points |
| Q1 2025 | -22% | +9.8 points |
| Q4 2024 | -7.8% | +8.1 points |
PLBY has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PLBY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $548K | -94% |
| Q2 2026 | -$571K | +$3.7M |
| Q1 2026 | -$8.7M | -$1M |
| Q4 2025 | $1.1M | +$1.9M |
| Q3 2025 | $9.8M | +$16.4M |
| Q2 2025 | -$4.3M | -$603K |
| Q1 2025 | -$7.7M | +$2.7M |
| Q4 2024 | -$743K | +$3.3M |
PLBY has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
PLBY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7.5% | -8.6M shares |
| 1 year | -5.7% | -6.4M shares |
| 3 years | +44% | +32.2M shares |
| 5 years | +189% | +69.4M shares |
| Available history | +2622% | +102M shares |
PLBY has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3M |
| Q1 2020 | — |
| Q4 2019 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PLBY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 11.2x | High |
| Q2 2026 | 14.5x | High |
| Q1 2020 | 0.0x | Very low |
| Q4 2019 | 68.5x | High |
PLBY's net debt is about 11 years of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PLBY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 43.0 | Neutral |
PLBY's weekly RSI is 49 (neutral) and its Stochastic is 43 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PLBY PE vs Consumer Cyclical Sector
| Metric | PLBY | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 18x | 69% above |
PLBY is trading at 31x earnings, a 69% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PLBY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.11 | 9.9% above |
| 20 week MA | $1.15 | 6.1% above |
| 50 week MA | $1.48 | 18% below |
| 100 week MA | $1.51 | 19% below |
| 200 week MA | $1.36 | 10% below |
PLBY has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PLBY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.0 | $10.7 | +6.5% |
| 2021 | $10.7 | $28.9 | +171% |
| 2022 | $28.9 | $2.91 | -90% |
| 2023 | $2.91 | $1.00 | -66% |
| 2024 | $1.00 | $1.50 | +50% |
| 2025 | $1.50 | $1.87 | +25% |
| 2026 YTD | $1.87 | $1.22 | -35% |
PLBY has the edge over LCID on returns for 2026, with the stronger performance.